Mycosis fungoides and Sezary syndrome

Blood. 1996 Oct 1;88(7):2385-409.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation
  • Child
  • Cytokines / analysis
  • Diagnosis, Differential
  • Disease Progression
  • Female
  • HLA Antigens / analysis
  • Herpesviridae / pathogenicity
  • Herpesviridae Infections / complications
  • Human T-lymphotropic virus 1 / pathogenicity
  • Humans
  • Immunologic Factors / therapeutic use
  • Incidence
  • Intercellular Adhesion Molecule-1 / analysis
  • Male
  • Middle Aged
  • Mycosis Fungoides* / diagnosis
  • Mycosis Fungoides* / epidemiology
  • Mycosis Fungoides* / etiology
  • Mycosis Fungoides* / pathology
  • Mycosis Fungoides* / therapy
  • Neoplasm Proteins / analysis
  • Neoplasm Staging
  • Oncogenes
  • PUVA Therapy
  • Precancerous Conditions / pathology
  • Prognosis
  • Retroviridae Infections / complications
  • Sezary Syndrome* / diagnosis
  • Sezary Syndrome* / epidemiology
  • Sezary Syndrome* / etiology
  • Sezary Syndrome* / pathology
  • Sezary Syndrome* / therapy
  • Skin Diseases / diagnosis
  • Skin Diseases / pathology
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / epidemiology
  • Skin Neoplasms* / etiology
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / therapy
  • Tumor Virus Infections / complications

Substances

  • Cytokines
  • HLA Antigens
  • Immunologic Factors
  • Neoplasm Proteins
  • Intercellular Adhesion Molecule-1